drugset / Trial / NCT04667533
Desidustat in the Treatment of Chemotherapy Induced Anemia
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, Open-label, Single Dose, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Desidustat for treatment of anemia in patients receiving chemotherapy.
Timeline
- Start
- 2020-11-11
- Primary completion
- 2022-03-27
- Completion
- 2022-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desidustat | Small molecule | 100 mg | — |
| Subject | Desidustat | Small molecule | 150 mg | — |
| Subject | Desidustat | Small molecule | 200 mg | — |